How a new approach to funding Alzheimer’s research could pay off (MIT News):
“More than 5 million Americans suffer from Alzheimer’s disease, the affliction that erodes memory and other mental capacities, but no drugs targeting the disease have been approved by the U.S. Food and Drug Administration since 2003…Lo and three co-authors propose [Read more…] about Rethinking Alzheimer’s research, beyond amyloid deposition, via new funding models